|
Index of reports
> Cases resulting in other serious reactions (70)
> Cases with Breast Cancer (29)
Below is the selection of adverse event reports related to Estrace (Estradiol Vaginal) that includes cases resulting in other serious reactions where reactions include breast cancer.
Reports 1 - 25 of 29 Next >>
Adverse event in 48 year old female receiving Estrace (Estradiol Vaginal)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 48 year old female, weighing 108.0 kg (237.7 pounds)
Adverse reactions / side effects: Weight Decreased, Breast Cancer, Depression
Suspect drug(s):
Estrace
Dosage: oral
Administration route: Oral
Indication: Anxiety
Start date: 1995-06-01
Estratest
Indication: Anxiety
Start date: 1983-05-21
End date: 1984-03-01
Premarin
Dosage: 1.25mg daily, oral
Administration route: Oral
Indication: Anxiety
Start date: 1984-03-01
Adverse event in 64 year old female receiving Estrace (Estradiol Vaginal)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 64 year old female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Estrace
Estratab
Premarin
Provera
Adverse event in 63 year old female receiving Estrace (Estradiol Vaginal)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 63 year old female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Estrace
Dosage: oral
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1989-05-22
End date: 1998-03-11
Premarin
Dosage: oral
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1989-03-01
End date: 1989-05-24
Provera
Dosage: oral
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1986-03-01
End date: 1989-05-24
Adverse event in female receiving Estrace (Estradiol Vaginal)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Cycrin
Estrace
Estradiol
Premarin
Provera
Adverse event in 63 year old female receiving Estrace (Estradiol Vaginal)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 63 year old female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Estrace
Dosage: oral
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1989-05-24
End date: 1998-03-11
Premarin
Dosage: oral
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1986-03-01
End date: 1989-05-24
Provera
Dosage: oral
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1986-03-01
End date: 1989-05-24
Adverse event in 48 year old female receiving Estrace (Estradiol Vaginal)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 48 year old female, weighing 108.0 kg (237.7 pounds)
Adverse reactions / side effects: Weight Decreased, Breast Cancer, Depression
Suspect drug(s):
Estrace
Dosage: oral
Administration route: Oral
Indication: Anxiety
Start date: 1995-06-01
Estratest
Indication: Anxiety
Start date: 1983-05-21
End date: 1984-03-01
Premarin
Dosage: 1.25mg daily, oral
Administration route: Oral
Indication: Anxiety
Start date: 1984-03-01
Adverse event in 74 year old female receiving Estrace (Estradiol Vaginal)
Reported by a consumer/non-health professional from United States on 2007-10-08
Patient: 74 year old female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Cycrin
Indication: Menopausal Symptoms
Estrace
Indication: Menopausal Symptoms
Estraderm
Indication: Menopausal Symptoms
Estradiol
Indication: Menopausal Symptoms
Estratab
Indication: Menopausal Symptoms
Estratest
Indication: Menopausal Symptoms
Ogen
Indication: Menopausal Symptoms
Premarin
Indication: Menopausal Symptoms
Prempro
Indication: Menopausal Symptoms
Provera
Indication: Menopausal Symptoms
Adverse event in female receiving Estrace (Estradiol Vaginal)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-07-27
Patient: female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Estrace
Indication: Hormone Therapy
Estrogen
Indication: Hormone Therapy
Medroxyprogesterone Acetate
Indication: Hormone Therapy
Premarin
Indication: Hormone Therapy
Prempro
Indication: Hormone Therapy
Provera
Indication: Hormone Therapy
Adverse event in female receiving Estrace (Estradiol Vaginal)
Reported by a consumer/non-health professional from United States on 2007-07-27
Patient: female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Estrace
Indication: Menopausal Symptoms
Estradiol Valerate
Indication: Ovarian Failure Postoperative
Estratest H.s.
Indication: Menopausal Symptoms
Premarin
Indication: Menopausal Symptoms
Provera
Indication: Menopausal Symptoms
Adverse event in 56 year old female receiving Estrace (Estradiol Vaginal)
Reported by a individual with unspecified qualification from United States on 2007-07-18
Patient: 56 year old female
Adverse reactions / side effects: Biopsy Breast Abnormal, Urinary Incontinence, Biopsy Endometrium Abnormal, Cystocele, Smear Cervix Abnormal, Road Traffic Accident, Neck Pain, Breast Microcalcification, Intervertebral Disc Degeneration, Back Pain, Breast Cancer, Pelvic Fracture, Radiculitis Lumbosacral, Accident, Rectocele, Uterine Prolapse, Bladder Disorder
Suspect drug(s):
Estrace
Dosage: 1 mg, unk
Indication: Menopause
Start date: 1998-04-01
End date: 1998-12-01
Premarin
Dosage: 0.625 mg, unk
Administration route: Oral
Indication: Menopause
Start date: 1994-07-01
End date: 1998-03-01
Prometrium
Dosage: 100 mg, unk
Indication: Menopause
Start date: 1999-11-01
End date: 2001-04-01
Provera
Dosage: 10 mg, unk
Administration route: Oral
Indication: Menopause
Start date: 1994-07-01
End date: 1997-01-01
Vivelle
Dosage: 0.05 mg/day, unk
Indication: Menopause
Start date: 2000-06-01
End date: 2002-02-01
Vivelle-DOT
Adverse event in female receiving Estrace (Estradiol Vaginal)
Reported by a consumer/non-health professional from United States on 2007-07-11
Patient: female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Activella
Dosage: oral
Administration route: Oral
Indication: Hormone Replacement Therapy
Estrace
Dosage: oral
Administration route: Oral
Indication: Hormone Replacement Therapy
Provera
Dosage: oral
Administration route: Oral
Indication: Hormone Replacement Therapy
Adverse event in 62 year old female receiving Estrace (Estradiol Vaginal)
Reported by a individual with unspecified qualification from United States on 2007-07-02
Patient: 62 year old female, weighing 99.8 kg (219.5 pounds)
Adverse reactions / side effects: Polyp Colorectal, Mammogram Abnormal, Fibrocystic Breast Disease, Intervertebral Disc Disorder, Postmenopausal Haemorrhage, Breast Microcalcification, Blood Cholesterol Increased, Benign Breast Neoplasm, Breast Hyperplasia, Breast Cancer, Tonsillectomy, Abscess Drainage, Mastitis, Radiotherapy, Malignant Breast Lump Removal, Appendicitis, Anal Fissure, Haematochezia, Hysterectomy, Uterine Dilation and Curettage, Colonoscopy Abnormal
Adverse event resulted in: hospitalization
Suspect drug(s):
Cycrin
Start date: 1999-01-01
Estrace
Dosage: unk, qhs
Start date: 1999-01-01
Estraderm
Start date: 1989-01-01
Estratest
Start date: 1990-01-01
End date: 1999-01-01
Premarin
Dosage: 0.625 unk, unk
Administration route: Oral
Start date: 1989-01-01
Prempro
Indication: Menopause
Start date: 1999-04-01
End date: 2002-04-01
Provera
Dosage: 10 mg, unk
Start date: 1989-01-01
Other drugs received by patient: Steroids NOS; Oxygen Therapy; Lotrel; Cardizem
Adverse event in 53 year old female receiving Estrace (Estradiol Vaginal)
Reported by a individual with unspecified qualification from United States on 2007-06-26
Patient: 53 year old female, weighing 47.6 kg (104.8 pounds)
Adverse reactions / side effects: Breast Cancer, Chondropathy, Joint Manipulation, Neuropathy, Rectal Polyp, Radiotherapy, Malignant Breast Lump Removal, Periarthritis, Paraesthesia, Rectal Polypectomy, Anxiety, Breast Microcalcification, Depression, Neuralgia
Suspect drug(s):
Climara
Indication: Menopause
Start date: 1995-06-22
End date: 1995-01-01
Estrace
Indication: Menopause
Start date: 1994-06-24
End date: 1996-02-26
Estraderm
Indication: Menopause
Start date: 1995-05-31
End date: 1995-01-01
Ortho-EST
Indication: Menopause
Start date: 1994-05-27
Prempro
Indication: Menopause
Start date: 1996-04-05
End date: 1996-10-11
Provera
Dosage: 10 mg, unk
Administration route: Oral
Indication: Menopause
Start date: 1994-05-27
End date: 1996-02-26
Adverse event in female receiving Estrace (Estradiol Vaginal)
Reported by a consumer/non-health professional from United States on 2007-06-12
Patient: female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Combipatch
Indication: Menopausal Symptoms
Start date: 2000-01-01
End date: 2000-09-01
Estrace
Dosage: duration of therapy: ^several years^
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1998-01-01
End date: 2000-01-01
Premarin
Administration route: Oral
Indication: Hormone Replacement Therapy
Prempro
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 2000-03-01
End date: 2001-02-01
Provera
Dosage: duration of therapy: ^several years^
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1998-01-01
End date: 2000-01-01
Other drugs received by patient: Bumetanide
Adverse event in 51 year old female receiving Estrace (Estradiol Vaginal)
Reported by a lawyer from United States on 2007-06-12
Patient: 51 year old female, weighing 59.0 kg (129.8 pounds)
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Climara
Indication: Menopausal Symptoms
Estrace
Indication: Menopausal Symptoms
Estradiol
Indication: Menopausal Symptoms
Estratest
Indication: Menopausal Symptoms
Premarin
Indication: Menopausal Symptoms
Progesterone
Indication: Menopausal Symptoms
Provera
Indication: Menopausal Symptoms
Adverse event in 67 year old female receiving Estrace (Estradiol Vaginal)
Reported by a lawyer from United States on 2007-05-30
Patient: 67 year old female
Adverse reactions / side effects: Biopsy Breast Abnormal, Breast Cancer in Situ, Pericardial Effusion, Haemangioma of Liver, Uterine Leiomyoma, Pleural Effusion, Injury, Mitral Valve Prolapse, Breast Cancer, Dyspnoea, Pneumonia, Pleurisy, Osteopenia, Cholelithiasis, Hysterectomy, Uterine Dilation and Curettage, Aspiration Pleural Cavity, Mastectomy, Salpingo-Oophorectomy Bilateral, Uterine Haemorrhage
Suspect drug(s):
Estrace
Dosage: unk, 1-2 weekly
Administration route: Topical
Indication: Menopausal Symptoms
Start date: 1988-11-01
End date: 1991-03-01
Estraderm
Dosage: 0.05 mg/day, tiwce weekly
Indication: Menopausal Symptoms
Start date: 1991-04-01
End date: 1994-01-01
Premarin
Dosage: .625 and .3 mg, unk
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1986-10-01
End date: 1995-08-01
Prempro
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1995-01-01
End date: 1996-01-01
Provera
Dosage: 10 mg, unk
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1983-06-01
End date: 1995-08-01
Adverse event in 56 year old female receiving Estrace (Estradiol Vaginal)
Reported by a individual with unspecified qualification from United States on 2007-04-16
Patient: 56 year old female, weighing 59.0 kg (129.7 pounds)
Adverse reactions / side effects: Tinnitus, Seroma, Hyperhidrosis, Depression Postoperative, Mammogram Abnormal, Hot Flush, Malaise, Breast Cyst, Uterine Leiomyoma, Bacterial Test Positive, Nervousness, Breast Cancer, Back Pain, Pain in Extremity, Breast Haematoma, Radiotherapy, Libido Decreased, Osteopenia, Bursitis, Dolichocolon, Pain, Breast Oedema, Radiation Skin Injury, Constipation, Gastritis, Abdominal Pain Upper, Weight Increased, Blepharoplasty, Fatigue, Body Dysmorphic Disorder, Nerve Root Lesion, Abdominal Distension, Depression, Oestrogen Receptor Assay Positive, Gastrooesophageal Reflux Disease, Intestinal Polyp, Scoliosis, Haemorrhoids, Deafness Neurosensory, Malignant Breast Lump Removal, Progesterone Receptor Assay Positive, Anxiety, Spinal Osteoarthritis, Asthenia, Hypertension
Suspect drug(s):
Estrace
Indication: Hormone Replacement Therapy
Estraderm
Indication: Hormone Replacement Therapy
Start date: 1985-01-01
End date: 1999-01-01
Medroxyprogesterone
Dosage: 5 mg, unk
Indication: Hormone Replacement Therapy
Start date: 1998-07-29
End date: 1999-10-01
Premarin
Indication: Hormone Replacement Therapy
Start date: 1985-01-01
End date: 1999-01-01
Provera
Indication: Hormone Replacement Therapy
Start date: 1985-01-01
End date: 1999-01-01
Other drugs received by patient: Inderal; Nexium
Adverse event in 65 year old female receiving Estrace (Estradiol Vaginal)
Reported by a physician from United States on 2007-04-03
Patient: 65 year old female, weighing 64.9 kg (142.7 pounds)
Adverse reactions / side effects: Diverticulitis, Breast Cellulitis, Exomphalos, Irritable Bowel Syndrome, Depression, Lymphadenectomy, Breast Cancer, Radiotherapy, Malignant Breast Lump Removal, Hernia Repair, Facet Joint Syndrome, Spondylitis, Anxiety, Cholelithiasis, Cholecystectomy, Spinal Osteoarthritis
Suspect drug(s):
Estrace
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1991-01-01
End date: 1996-01-01
Estraderm
Indication: Hormone Replacement Therapy
Start date: 1988-08-08
End date: 1991-01-01
Premarin
Indication: Hormone Replacement Therapy
Start date: 1996-01-01
End date: 2001-01-01
Prempro
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1996-01-01
End date: 2001-01-01
Adverse event in 60 year old female receiving Estrace (Estradiol Vaginal)
Reported by a lawyer from United States on 2007-03-30
Patient: 60 year old female, weighing 81.6 kg (179.6 pounds)
Adverse reactions / side effects: Biopsy Breast Abnormal, Mammogram Abnormal, Hot Flush, Ultrasound Breast Abnormal, Depression, Breast Hyperplasia, Oestrogen Receptor Assay Positive, Menorrhagia, Breast Cancer, Premenstrual Syndrome, Ovarian Cyst, Breast Mass, Meniscus Operation, Progesterone Receptor Assay Positive, Hysterectomy, Meniscus Lesion, Osteoarthritis, Hyperplasia, Adenocarcinoma, Needle Biopsy Site Unspecified Abnormal, Arthroscopy, Salpingo-Oophorectomy Bilateral
Suspect drug(s):
Aygestin
Dosage: 5 mg, unk
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 2000-01-10
End date: 2000-03-03
Cycrin
Dosage: unk, unk
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1999-08-04
Cycrin
Dosage: 5 mg, unk
Administration route: Oral
Estrace
Dosage: 0.1 %, unk
Start date: 1999-07-06
End date: 2001-08-15
Estraderm
Dosage: 0.1 mg/day unk
Indication: Hormone Replacement Therapy
Start date: 1999-06-09
End date: 1999-12-10
Estrogen NOS
Indication: Hot Flush
Loestrin 1.5 / 30
Dosage: 1/20, unk
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1999-08-16
Ogen
Indication: Hot Flush
Premarin
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1985-01-01
End date: 1997-01-01
Premarin
Dosage: 0.625 mg, unk
Administration route: Oral
Start date: 1999-09-13
Premarin
Dosage: 1.25 mg, unk
Administration route: Oral
Premarin
Dosage: 0.3 mg, unk
Administration route: Oral
End date: 2001-08-15
Prempro
Provera
Dosage: 10 mg, ten days of each month
Administration route: Oral
Vivelle
Dosage: 0.1 mg/day, unk
Indication: Hormone Replacement Therapy
Start date: 2000-01-10
Vivelle-DOT
Dosage: 0.1 mg/day, unk
Indication: Hormone Replacement Therapy
Start date: 2000-02-06
End date: 2001-08-27
Other drugs received by patient: Rhinocort; Vitamin E; Multi-Vitamins; Vitamin B6; Calcium
Adverse event in 61 year old female receiving Estrace (Estradiol Vaginal)
Reported by a individual with unspecified qualification from United States on 2007-03-28
Patient: 61 year old female, weighing 89.8 kg (197.5 pounds)
Adverse reactions / side effects: Breast Cancer, Biopsy Breast Abnormal, Breast Mass, Malignant Breast Lump Removal, Progesterone Receptor Assay Positive, Haemangioma of Liver, Limb Discomfort, Oedema Peripheral, Depression, Lymphadenectomy, Knee Arthroplasty, Oestrogen Receptor Assay Positive, Lung Infiltration
Adverse event resulted in: hospitalization
Suspect drug(s):
Estrace
Indication: Night Sweats
Estratab
Dosage: 0.625 mg, qd
Indication: Night Sweats
Estropipate
Dosage: 1 mg, unk
Indication: Amnesia
Premarin
Dosage: 0.625 mg, unk
Indication: Affective Disorder
Prempro
Indication: Amnesia
Provera
Dosage: 2.5 mg, qd
Indication: Hormone Replacement Therapy
Vivelle
Indication: Hormone Replacement Therapy
Vivelle-DOT
Indication: Hormone Replacement Therapy
Other drugs received by patient: Fish OIL; Alprazolam; Celebrex
Adverse event in 59 year old female receiving Estrace (Estradiol Vaginal)
Reported by a individual with unspecified qualification from United States on 2007-03-27
Patient: 59 year old female, weighing 96.1 kg (211.5 pounds)
Adverse reactions / side effects: Abdominal Pain, Abdominal Operation, Urinary Incontinence, Cervix Disorder, Incisional Hernia, Upper Respiratory Tract Infection, Central Venous Catheterisation, Postmenopausal Haemorrhage, Colostomy, Tendonitis, Rectal Prolapse, Breast Cancer, Enterostomy, Pelvic Abscess, Bursitis, non-Cardiac Chest Pain, Menopause, Cholelithiasis, Emotional Distress, Diverticulum, Vaginal Infection, Uterine Haemorrhage, Oophorectomy, Bladder Prolapse, Post Procedural Complication, Pain, Pelvic Pain, Cardiac Valve Disease, Hypercholesterolaemia, Ovarian Cystectomy, Fibrocystic Breast Disease, Basal Cell Carcinoma, Haemorrhagic Ovarian Cyst, Injury, Renal Failure Acute, Cataract, Mass, Urinary Tract Infection, Synovitis, Hernia, Tubal Ligation, Osteoarthritis, Adhesiolysis, Small Intestinal Resection, Radical Mastectomy, Uterine Prolapse Repair, Hypertension, Leukopenia, Abdominal Adhesions
Adverse event resulted in: hospitalization
Suspect drug(s):
Estrace
Dosage: 1 mg, qd
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1994-05-23
Estrace Vaginal Cream
Dosage: 2 g oncde per week
Indication: Menopausal Symptoms
Start date: 1994-04-27
Estrace Vaginal Cream
Dosage: 2 g once per week
Start date: 1994-05-23
Estraderm
Dosage: 0.1 mg, unk
Start date: 1999-08-02
Loestrin 1.5 / 30
Dosage: 1.5 mg, unk
Start date: 1994-09-08
Premarin
Dosage: 0.625 mg, qd
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1984-09-26
End date: 1997-10-01
Prempro
Dosage: .625/5 mg
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1997-06-25
End date: 2001-12-02
Provera
Dosage: 2.5 mg, qd
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1994-05-23
Provera
Dosage: 5 mg, qd
Administration route: Oral
Start date: 1996-01-02
End date: 1997-10-01
Other drugs received by patient: Prilosec; Avalide
Adverse event in 54 year old female receiving Estrace (Estradiol Vaginal)
Reported by a lawyer from United States on 2007-03-14
Patient: 54 year old female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Estrace
Indication: Hormone Therapy
Estradiol
Indication: Hormone Therapy
Premarin
Indication: Hormone Therapy
Provera
Indication: Hormone Therapy
Adverse event in 57 year old female receiving Estrace (Estradiol Vaginal)
Reported by a individual with unspecified qualification from United States on 2007-03-01
Patient: 57 year old female, weighing 56.7 kg (124.7 pounds)
Adverse reactions / side effects: Breast Cancer, Back Pain, Pain in Extremity, Angina Pectoris, Osteoporosis, Musculoskeletal Pain, Tachycardia, Radiotherapy, Lumbar Radiculopathy, Cervical Conisation, Smear Cervix Abnormal, Catheterisation Cardiac, Palpitations, Intervertebral Disc Disorder, Mastectomy, Spinal Osteoarthritis, Gastrooesophageal Reflux Disease
Adverse event resulted in: hospitalization
Suspect drug(s):
Estrace
Indication: Hormone Replacement Therapy
Start date: 1993-08-12
End date: 1993-09-14
Estraderm
Dosage: 0.05 mg patch
Indication: Hormone Replacement Therapy
Start date: 1993-09-14
End date: 1994-08-08
Premarin
Dosage: 0.3-0.625mg
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1989-06-06
End date: 1993-08-12
Provera
Dosage: 2.5-10mg
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1989-06-06
End date: 1994-09-14
Other drugs received by patient: Maxzide; Atenolol; Norethindrone; Tamoxifen Citrate
Adverse event in female receiving Estrace (Estradiol Vaginal)
Reported by a individual with unspecified qualification from United States on 2007-02-22
Patient: female, weighing 74.8 kg (164.6 pounds)
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Activella
Dosage: unk, unk
Indication: Menopausal Symptoms
Start date: 2000-11-28
End date: 2001-06-01
Climara
Dosage: .05 mg, unk
Indication: Menopausal Symptoms
Start date: 1997-07-22
End date: 1998-05-01
Estrace
Dosage: 1 mg, unk
Indication: Menopausal Symptoms
Start date: 1992-09-11
End date: 1992-10-01
Estratab
Dosage: .3 mg, unk
Indication: Menopausal Symptoms
Start date: 1998-11-20
End date: 1999-11-01
Estratest
Dosage: unknown
Indication: Menopausal Symptoms
Start date: 1991-12-17
End date: 1992-05-01
Medroxyprogesterone
Dosage: 10 mg, unk
Indication: Menopausal Symptoms
Start date: 1993-01-01
End date: 1995-01-01
Menest
Dosage: .3 mg, unk
Indication: Menopausal Symptoms
Start date: 1999-10-26
End date: 2000-05-01
Ogen
Dosage: 1.25 mg, unk
Indication: Menopausal Symptoms
Start date: 1991-11-15
End date: 1991-12-01
Premarin
Dosage: .9 mg, unk
Indication: Menopausal Symptoms
Start date: 1991-04-10
End date: 1994-11-01
Premarin
Dosage: .625 mg, unk
Start date: 1991-04-10
End date: 1994-11-01
Prempro
Dosage: 0.625/2.5 mg, unk
Indication: Menopausal Symptoms
Start date: 2000-05-10
End date: 2000-11-01
Provera
Dosage: 2.5 - 10 mg, unk
Indication: Menopausal Symptoms
Start date: 1991-04-10
End date: 1999-08-01
Other drugs received by patient: Premarin; Progesterone; Femhrt
Adverse event in female receiving Estrace (Estradiol Vaginal)
Reported by a lawyer from United States on 2007-02-20
Patient: female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Estrace
Indication: Hormone Replacement Therapy
Start date: 1984-01-01
End date: 2003-02-01
Estradiol
Indication: Hormone Replacement Therapy
Start date: 1984-01-01
End date: 2003-02-01
Estratest
Indication: Hormone Replacement Therapy
Start date: 1984-01-01
End date: 2003-02-01
Premarin
Indication: Hormone Replacement Therapy
Start date: 1984-01-01
End date: 2003-02-01
Prempro
Indication: Hormone Replacement Therapy
Start date: 1984-01-01
End date: 2003-02-01
Provera
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1984-01-01
End date: 2003-02-01
Page 1 Next >>
|
